Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  MACEDONIAN STOCK EXCHANGE  >  Alkaloid AD Skopje    ALK   MKALKA101011

 SummaryNewsCompany 
Company
Alkaloid AD Skopje engages in the processing of botanical raw material and manufacturing drugs, cosmetics, and chemical products.It operates through the following segments: Pharmaceuticals, Chemicals, Cosmetics, and Botanicals.The Pharmaceuticals segment involves in producing medicines for human... 
Sector
Pharmaceuticals
Calendar

- No events available -

More about the company
Latest news on ALKALOID AD SKOPJE
08/10 ALKALOID SKOPJE : The Mayor of Zagreb visits Alkaloid Skopje, August 9, 2017
07/28 ALKALOID SKOPJE : marked growth in consolidated sales
04/27 ALKALOID SKOPJE : marked 10% growth in consolidated sales
04/12 ALKALOID SKOPJE : Dividend Payments for 2016
03/03 ALKALOID SKOPJE : Annual shareholders meeting
02/28 ALKALOID SKOPJE : marked 6% growth in consolidated sales, investments of MKD 712..
2016 ALKALOID SKOPJE : Notification on changes in Managing Board
2016 ALKALOID SKOPJE : marked 5% growth in consolidated sales, investments of MKD 546..
2016 ALKALOID AD SKOPJE : with increased consolidated sales by 4%, increase of consol..
2016 ALKALOID AD SKOPJE : with increased consolidated sales by 2% and 53 new employme..
More news
Sector news : Generic Pharmaceuticals
10:27pDJALLERGAN : Loses Patent Fight in Federal Court
06:09pDJDaimler Reshapes Company to Meet Challenges of Changing Industry -- Update
06:06p Miners provide foundation for FTSE while ConvaTec plummets
03:29p ASTRAZENECA : Pharma and medtech industries prepare for hard Brexit
10:45a CONVATEC : slashes revenue growth outlook, shares slump
More sector news : Generic Pharmaceuticals
Managers
NameTitle
Zhivko Mukaetov Chief Executive Officer
Miodrag Micajkov Chairman-Supervisory Board
Viktor Stojchevski Chief Financial Officer
Nikola Dimovski Head-Information Technology & Telecommunications
Natasha Nasteva Head-Global Regulatory & Medical Affairs